Massmutual Trust CO Fsb Revance Therapeutics, Inc. Transaction History

Massmutual Trust CO Fsb

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 03, 2024	BUY	$5.81 - $11.2 $255 - $492	44 Added 31.65%	183 $1,000
Q3 2023 Oct 03, 2023	BUY	$11.47 - $25.07 $286 - $626	25 Added 21.93%	139 $1,000
Q4 2022 Jan 06, 2023	SELL	$18.32 - $30.66 $274 - $459	-15 Reduced 11.63%	114 $2,000
Q3 2022 Oct 07, 2022	BUY	$14.33 - $28.47 $1,848 - $3,672	129 New	129 $3,000
Q1 2022 Apr 08, 2022	SELL	$12.36 - $20.31 $444 - $731	-36 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$12.46 - $27.87 $448 - $1,003	36 New	36 $1,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

Stay updated on Massmutual Trust CO Fsb with notifications on news.